Shire has announced that they will be initiating a Natural History study for MPS IIIB

Official Title: “An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type III (MPS IIIB, Sanfilippo Syndrome Type B)”

The purpose of this study is to evaluate the natural course of disease progression in Mucopolysaccharidosis Type III (MPS IIIB) patients who are untreated to identify potential surrogate endpoints that may be utilized in future treatment trials of MPS IIIB using predefined assessments including standardized clinical, biochemical, neurocognitive, developmental, and imaging measures.

Visit Clinicaltrialsfeeds.org or Clinicaltrials.gov for more information.

This entry was posted in News. Bookmark the permalink.

Comments are closed.